http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104039325-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd708a84f841d099bd81f8e8d72a610a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2012-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2272d316a064648b4eb7c9139dd60d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cda6c4eb22191fb5385fe96d7ab4b75f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b4faf5e17d9c43349f4b03f6283e46b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c30bac0238a89ffb3f88d983fe6a5a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ec3b5662a3a8188933182ab20805273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec5516c8a3b1271241824b282226ea88
publicationDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104039325-A
titleOfInvention Uses of Bruton's Tyrosine Kinase (BTK) Inhibitors
abstract The present invention provides methods for treating hematological cancers comprising administering an anticancer agent to a subject identified as having increased mobilization of lymphocyte subsets from the malignancy following administration of an irreversible Btk inhibitor. Also provided are methods of identifying a subject for treatment and analyzing cells mobilized from a hematological malignancy following administration of an irreversible Btk inhibitor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114681459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104407067-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109996544-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107530293-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104407067-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107106565-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113546054-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016065674-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108472258-A
priorityDate 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012183535-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467628811

Total number of triples: 46.